H1N1 Continues to Affect the Young
The availability of H1N1 vaccine is still less than what manufacturers had predicted and what federal health officials had wanted. Still, the 38 million doses currently ready for states to order is 11 million more than what was available a week ago, according to the Centers for Disease Control and Prevention.
“The pace of our progress is picking up,” said Rear Adm. Anne Schuchat, MD, director of the CDC’s National Center for Immunization and Respiratory Diseases.
Schuchat stopped short of predicting when the supply of vaccine would be enough to become readily available to the general public.
States, and in some cases municipalities, are responsible for determining how best to distribute limited supplies. In most areas, vaccinations are directed toward those at highest risk of spreading the disease or suffering the worst consequences.
Children remain among the groups most vulnerable. The virus is now blamed for 129 pediatric deaths in the U.S. Approximately two-thirds of these children had underlying neurological or respiratory conditions, Schuchat said.
According to the CDC, influenza activity is “widespread” in 48 states, with 7.7 percent of doctor’s office visits from patients reporting flu-like symptoms. That’s down slightly from last week’s figure of 8 percent. However, federal health officials say it’s too early to say whether H1N1 activity has peaked.
“Flu season can last until May,” Schuchat sait. “So, we really don’t know what trajectory we’ll see with this virus or with the flu season in general.”
Follow Jonathan on: Twitter Facebook Other Blogs